⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

George ColvinDO

Internal Medicine · Woodhaven, NY 11421

NPI: 1609866599

Share:

35

🟠 Elevated

🤖 ML Fraud Detection Score: 88%

Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.

Learn more →

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribing

Risk indicators are statistical patterns, not allegations. Learn more

396

Total Claims

$38K

Drug Cost

33

Beneficiaries

$1,145

Cost/Patient

Risk Score Breakdown 35/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+2404%

Opioid rate vs peers

56.1% vs 2.2% avg

-19%

Cost per patient vs peers

$1,145 vs $1,411 avg

-36%

Brand preference vs peers

6.8% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

🤖

ML fraud detection score of 88% indicates prescribing patterns with significant similarity to confirmed fraud cases. 18 out of 20 decision trees flagged this provider.

⚠️

Opioid prescribing rate is 2,404% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

56.1%

Opioid Rate

222

Opioid Claims

$27K

Opioid Cost

8.6%

Long-Acting Rate

This provider's opioid prescribing rate of 56.1% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

93% generic

Brand: 27 claims · $23K

Generic: 369 claims · $14K

Patient Profile

61

Avg Age

58%

Female

1.15

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About